Research Article | Open Access
Antibacterial Membrane with a Bone-Like Structure for Guided Bone Regeneration
An antibacterial membrane with a bone-like structure was developed for guided bone regeneration (GBR) by mineralising acellular bovine pericardium (ABP) and loading it with the antibiotic minocycline. The bovine pericardium (BP) membrane was processed using physical and chemical methods to remove the cellular components and obtain ABP membranes. Then, the ABP membranes were biomimetically mineralised using a calcium phosphate-loaded agarose hydrogel system aided by electrophoresis. Minocycline was adsorbed to the mineralised ABP membrane, and the release profile in vitro was studied. The membranes were characterised through scanning electron microscopy, diffuse reflectance-Fourier transform infrared spectroscopy, and X-ray diffraction. Results showed that the ABP membrane had an asymmetric structure with a layer of densely arranged and irregularly aligned collagen fibrils. Collagen fibrils were calcified with the formation of intrafibrillar and interfibrillar hydroxyapatites similar to the bone structure. Minocycline was incorporated into the mineralised collagen membrane and could be released in vitro. This process endowed the membrane with an antibacterial property. This novel composite membrane offers promising applications in bioactive GBR.
Guided bone regeneration (GBR) is a well-established therapy that promotes bone regeneration. GBR is based on a barrier membrane that prevents fibrous and epithelial tissues from invading the bone defect zone and thus blocks osteogenesis . Improving the membrane biocompatibility to induce osteogenesis and using a mechanism to support the space of bone regeneration and antibacterial properties are required for GBR. Bioabsorbable collagen membranes have been successfully used in clinical applications. However, these membranes still present certain limitations, such as inferior mechanical properties and rapid degradation of membranes, which are associated with connective tissue invasion and infection, among others.
Acellular bovine pericardium (ABP) is a typical natural collagen membrane that has attracted considerable interest because of its potential application in bioprosthetics [2–6]. ABP has also been utilised as a barrier membrane in GBR . ABP is composed of native extracellular matrices that contain numerous collagen fibres, several elastin fibres, and various glycosaminoglycans with a highly interconnected porous structure (average pore size of 25 μm and interconnectivity/porosity of 60%) on both the surface and the internal structure.
Bone is a composite material with a basic microstructure characterised by calcified collagen fibrils forming a scaffold as a template for hydroxyapatite (HA) crystal nucleation and growth. Plate-like HA is preferentially oriented with the -axis parallel to the longitudinal axis of the fibrils . In our previous study, we have developed a technique to remineralise the dentin collagen matrix .
Infection is a significant health care burden and is considered as the major reason for GBR failure in clinical practice. Therefore, antibiotic drug-loaded membranes are highly demanded. However, the incorporation of antibiotics into biomaterials often results in biocompatibility attenuation. Minocycline is a second-generation semisynthetic tetracycline antibiotic that exhibits pleiotropic biologic activities besides its anti-inflammatory activities. Minocycline can also enhance bone formation by inhibiting the activity of osteoclasts, promoting the activity of osteoblasts, and inhibiting connective tissue breakdown and bone resorption . Thus, minocycline is a good candidate for GBR membrane design. We have previously developed a minocycline-releasing HA-gelatin hybrid material for bone defect repair .
The current study aims to develop an antibacterial membrane with a bone-like structure for GBR. The mechanism, biocompatibility, and antibacterial property of the ABP membrane were improved through mineralisation and minocycline loading.
2. Materials and Methods
2.1. BP Source
Fresh BP was obtained from a bovine heart (20–22 months old). External fat and adherences were removed, and BP samples were obtained. The obtained BP samples were stored at −80°C until use in the laboratory.
2.2. BP Decellularisation
The BP samples were freeze-thawed (−80°C for 4 h followed by 37°C for 30 min) for five times and ultrasonically cleansed for 3 min after each cycle. The samples were immersed in sterile phosphate-buffered saline (PBS) on a shaker (300 rpm; 4°C, 24 h), and the medium was refreshed every 6 h. Then, the samples were treated with 0.4% TritonX-100 for 48 h on a shaker (300 rpm; 4°C; the medium was refreshed every 24 h) and ultrasonically cleansed for 2 min after each cycle. The samples were again immersed in PBS on a shaker (300 rpm; 4°C, 24 h; the medium was refreshed every 6 h) to obtain the ABP. The acquired ABP was characterised via scanning electron microscopy (SEM) (Sirion 200, FEI Co., Hillsboro, Oregon, USA). For SEM observation, fresh ABP was dehydrated in a graded ethanol series (50%, 70%, 80%, 90%, 95%, and 100%) and then critical point-dried (Critical Point Drying, K850, Quorum, England) before gold sputtering.
2.3. Agarose Gel Preparation
An agarose gel with 0.13 M CaCl2 was prepared by adding agarose powder (1.0 g) to 100 mL of 0.13 M CaCl2 solution. An agarose gel with 0.26 M Na2HPO4 was prepared by adding agarose powder (1.0 g) to 100 mL of 0.26 M Na2HPO4 solution containing 500 ppm fluoride; 0.1 M NaOH and 0.1 M HCl were used to adjust the pH to 6.5. The mixtures were enhanced for 30 min and then heated to 100°C until the agarose was completely dissolved.
2.4. Mineralisation of ABP Membranes
ABP membranes were mineralised using a calcium phosphate-loaded agarose gel system aided by electrophoresis in accordance with our previous protocol . The electrophoresis aiding the mineralising system (Figure 1) consisted of a two-way horizontal polyether tube, two plastic cells, two graphite electrodes, and electrophoresis. Agarose gel with 20 mL of 0.13 M CaCl2 and 20 mL of 0.26 M Na2HPO4 containing 500 ppm fluoride (pH 6.5) was placed on the two sides of the tube separated by the ABP membrane. The tube was then connected to the plastic cells. Electrodes were placed at the bottom of the cells, which were filled with 100 mL of 0.9% NaCl solution. The electric current was constantly maintained at 20 mA during electrophoresis. The gel and NaCl solution were refreshed every 2 h, and their exchange defined the completion of a mineralisation cycle. ABP was ultrasonically cleansed with 100 mL of sterile PBS solution for 2 min after each cycle. The sample mineralised through three, six, and nine cycles was assessed and characterised using SEM, X-ray diffraction (XRD; X’ Pert Pro, Philips Almelo, Netherlands), diffuse reflectance-Fourier transform infrared spectroscopy (DR-FTIR; Nicolet 8700 Thermo Scientific Instrument Co., Friars Drive Hudson, New Hampshire, USA), thermogravimetric analysis (TGA), and differential thermal analysis (DTA; ATA 449C Jupiter, NETZSCH, Germany).
2.5. Preparation of Minocycline-Loaded Mineralised ABP
Minocycline hydrochloride was dissolved in sterile PBS to obtain a stock solution of 500 mg/L. The mineralised membranes were immersed in 500 mg/L minocycline solution in a constant-temperature air bath oscillator (100 r/min) at 37°C for 48 h. The membranes were rinsed thrice, ultrasonically cleansed with deionised water for 5 min, and then lyophilised to obtain the final membranes.
The release of minocycline from the composite membranes in vitro was determined by incubating the 10 mm diameter membranes in 1 mL of sterile PBS and in a constant-temperature air bath oscillator (100 r/min) at 37°C. Individual samples were centrifuged at appropriate time intervals (1, 3, 5, and 7 days). The supernatant was collected to measure the content of minocycline, and the same amount of fresh PBS was refilled to continue the test. The amount of minocycline in the supernatant was measured via ultraviolet spectrophotometry at 348 nm (). The mineralised ABP membrane without minocycline loading treated as above served as the control.
Statistical differences were analysed using ANOVA and deemed significant at .
3. Results and Discussion
3.1. ABP Membrane
Cellular components were removed, and a fibrous matrix with high interconnectivity remained after the decellularisation of fresh BP membrane (Figures 2(a)–2(d)). The ABP membrane showed an asymmetric structure, in which the serosal layer fibres consisted of densely arranged collagen fibrils (Figure 2(c)), whereas the external layer fibres consisted of irregularly aligned collagen fibrils (Figure 2(d)). Given its asymmetric structure, ABP is a highly suitable GBR membrane. The dense layer can effectively isolate the bone defect from the invasion of surrounding connective fibrous tissues, whereas the loose layer can improve adhesion force to bone and stabilise blood clots. By contrast, the ABP membrane possessed a highly interconnected porous structure both on the surface and in its internal structure. Porosity is an important characteristic that enables a barrier membrane to allow nutritional elements to diffuse.
3.2. Mineralised ABP Membrane
The mineralised ABP membrane appeared white. The membrane became relatively stiff, whereas the ABP membrane became soft. Mineralisation also improved surface hardness.
XRD spectra confirmed that the precipitates that formed on the remineralised ABP membrane were HA crystals (Figure 3). Prior to mineralisation, the ABP membrane showed a typical characteristic of collagen, with wide peaks at approximately = 20° (Figure 3(a)). However, the XRD pattern of the mineralised ABP membranes corresponded well to the expected peaks of HA, such as typical diffraction peaks (002) at = 25.8°, (211) at = 31.9°, (112) at = 32.4°, and (300) at = 33.3°. The result of XRD spectra indicated that the ratio of the diffraction intensity of the -axis (002) reflection of HA to the diffraction intensity of the -axis (300) reflection of HA considerably increased as the mineralisation time was prolonged (Figure 3(b–d)). This finding suggested that HA precipitates were located along the -axis on the ABP membrane surface and corresponded well to the SEM observation (Figure 4(c)).
In the FTIR spectrum of the ABP membrane (Figure 4(a)), the peak at 3616 cm−1 was ascribed to NH3 groups (N-H vibrational bands); the peaks at 1631, 1553, and 3616 cm−1 were ascribed to amide I (C=O vibrational band), amide II (N-H bending band), and amide III (C-N vibrational band), respectively; and the peaks at 1246 and 1077 cm−1 were ascribed to –OH groups. These peaks exhibit the character of collagen protein. The FTIR spectra of the mineralised ABP membranes were characterised by the predominant distinctive PO4 vibrational bands (P-O) at approximately 1023 cm−1 (Figure 4(b–d)). In the mineralised ABP membrane, the peaks ascribed to amide groups gradually diminished when the number of mineralising cycles was increased.
The SEM images in Figure 5 show that the collagen fibrils of the ABP membranes were completely mineralised from the surface to the interior. As the mineralisation time was prolonged, many HA crystals formed on the ABP membranes, and the spaces between the collagen fibrils were occupied by HA crystals. After 6 h of mineralisation (three mineralising cycles), nano-HA crystals nucleated and increased along the collagen fibrils, resulting in their calcification (Figures 5(a), 5(d), and 5(g)). However, the internal cross-sectional images show that several collagen fibrils were not calcified. This result indicated that calcification was slower in the internal structure than on the surface. The number of HA crystals that formed on the ABP collagen scaffolds increased after 12 h of mineralisation (six mineralising cycles) (Figures 5(b), 5(e), and 5(h)). Moreover, the dense serosal layer surface was completely covered by HA crystal clusters (Figure 5(b)). After 18 h of mineralisation (nine mineralising cycles), collagen fibrils were hardly identified, and densely packed needle-shaped HA crystals were arranged perpendicular to the dense serosal layer surface with its -axis (Figure 5(c)).
The basic microstructure of bone comprises a calcified collagen matrix, in which the apatite phase is classified into intrafibrillar and interfibrillar crystallites. Intrafibrillar crystallites occupy interstitial spaces (e.g., hole zones and pore spaces) that separate collagen fibrils . The SEM images in Figure 6 show that precipitated particles were regularly and homogenously distributed along the collagen fibrils in a “string-of-beads” structure on the ABP membrane surface and in the interior, indicating intrafibrillar mineralisation. With substantial mineralisation, intrafibrillar minerals may act as apatite seed crystallites to facilitate the growth of nanocrystals along the collagen fibril, resulting in continued mineral buildup on the exterior and the formation of interfibrillar mineralisation. Interfibrillar HA was embedded between collagen fibrils, exhibiting a “corn-on-the-cob” appearance in certain regions (Figure 6) because of interfibrillar mineralisation. These observations may correspond well with interfibrillar or extrafibrillar mineralisation, which shows the natural appearance of a bone structure. Thus, we confirmed that the mineralisation can create a bone-like structure.
The TGA/DTA data for ABP and mineralised (12 mineralised cycles) membranes are shown in Figure 7. The TGA curve illustrates the mass of ABP samples at different temperatures. The weight of the ABP membrane gradually decreased by 12.916% from 32.47°C to 168.41°C and that of the mineralised ABP membrane gradually decreased by 4.695% from 24.2°C to 103.7°C. This decrease corresponded to the loss of adsorbed water, which was indicated by a small endothermic peak in the DTA curves. The weight of the ABP membrane sharply decreased by 53.588% from 168.41°C to 638.38°C and that of the mineralised ABP membrane by only 25.570% from 203.7°C to 561.7°C. These changes may be attributed to organic collagen decomposition, which was indicated by a small endothermic peak in the DTA curves. The overall weight loss of the ABP sample was 76.504% (i.e., 23.496% remained), whereas that of the remineralised ABP sample was 30.265% (i.e., 69.735% remained). Thus, the mineralised inorganic component (HA crystals) should be approximately 46.239% (the reminding remineralised ABP sample 69.735% minus the remaining organic component 23.496%, namely, 69.735% minus 23.496%). The inorganic mineral component had a structure similar to that of the bone for the mineralised ABP membrane after 18 h of remineralisation. This result confirms the successful establishment of a bone-like structure.
Many researchers have developed several polymer-inorganic composite membranes to mimic the bone hybrid structure; these composite membranes include poly(L-lactide)/poly(lactic-co-glycolic acid) , poly(L-lactide-co-glycolide-co-ε-caprolactone) , polycaprolactone , poly(L-lactic acid)-polysiloxane , chitosan-silica , and poly(L-lactide-co-ε-caprolactone) . These composite membranes exhibit improved mechanical strength and biocompatibility. However, composite materials are composed of inorganics and organics that are generally not collagen, thereby creating a bone structure that considerably differs from the natural bone structure. Compared with these composite materials, the mineralised ABP membrane is more compatible because of its capacity to support the formation of a bone-like structure.
3.3. Mineralised ABP Membrane Loading Minocycline and Its Release Profile
After minocycline loading, the membrane turned faint yellow, whereas the mineralised ABP membrane without minocycline became white. Figure 8 illustrates the time-dependent release of minocycline from the composite membrane into the supernatant. No significant difference in the amount of released minocycline () was observed, suggesting that the minocycline release remained nearly constant. Minocycline is a semisynthetic derivative of tetracycline. This compound can bind to HA crystals, and this binding property may contribute to its constant release. The nature of its release differs from that observed in our previous study  possibly because the extremely small amount of minocycline cannot overcome the binding ability to HA crystals. In other words, minocycline is bound under saturation, and only a small amount of passive adsorbed minocycline can be found on the composite.
As discussed above, we developed a novel low-cost GBR membrane with a bone-like structure and a minocycline-releasing property by using simple devices and basic materials. This membrane may improve the mechanical and antibacterial properties and biocompatibility of the collagen membrane. Further, the current membrane can be improved by loading with bioactive molecules, such as growth factors [18, 19]. Certainly, further biological evaluation is needed to substantiate this claim.
We developed an antibacterial GBR membrane with a bone-like structure composed of a calcified collagen matrix and minocycline. This composite GBR membrane may provide a potential base to develop other bioactive GBR membranes.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
This work was supported by Grant no. 81061160511 and Grant N_HKU 776/10 through the National Natural Science Foundation of China/Research Grants Council Joint Research Scheme and by Grant no. 9021091203 through key programs for science and technology development of Anhui province.
- R. Dimitriou, G. I. Mataliotakis, G. M. Calori, and P. V. Giannoudis, “The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence,” BMC Medicine, vol. 10, article 81, 2012.
- G. Goissis, A. de Fátima Giglioti, and D. M. Braile, “Preparation and characterization of an acellular bovine pericardium intended for manufacture of valve bioprostheses,” Artificial Organs, vol. 35, no. 5, pp. 484–489, 2011.
- A. Gubitosi, G. Docimo, D. Parmeggiani et al., “Acellular bovine pericardium dermal matrix in immediate breast reconstruction after Skin Sparing Mastectomy,” International Journal of Surgery, vol. 12, supplement 1, pp. 205–208, 2014.
- J. Shen and Z. W. Xu, “Combined application of acellular bovine pericardium and hyaluronic acid in prevention of postoperative pericardial adhesion,” Artificial Organs, vol. 38, no. 3, pp. 224–230, 2014.
- S. Mathapati, D. K. Bishi, S. Guhathakurta et al., “Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering,” Materials Science and Engineering C, vol. 33, no. 3, pp. 1561–1572, 2013.
- X. C. Dong, X. F. Wei, W. Yi et al., “RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering,” Journal of Materials Science: Materials in Medicine, vol. 20, no. 11, pp. 2327–2336, 2009.
- M. Bai, T. Zhang, T. Ling et al., “Guided bone regeneration using acellular bovine pericardium in a rabbit mandibular model: in-vitro and in-vivo studies,” Journal of Periodontal Research, vol. 49, no. 4, pp. 499–507, 2014.
- G. M. Luz and J. F. Mano, “Mineralized structures in nature: examples and inspirations for the design of new composite materials and biomaterials,” Composites Science and Technology, vol. 70, no. 13, pp. 1777–1788, 2010.
- X.-T. Wu, Y. Cao, M. L. Mei, J.-L. Chen, Q.-L. Li, and C. H. Chu, “An electrophoresis-aided biomineralization system for regenerating dentin- and enamel-like microstructures for the self-healing of tooth defects,” Crystal Growth & Design, vol. 14, no. 11, pp. 5537–5548, 2014.
- M. O. Griffin, G. Ceballos, and F. J. Villarreal, “Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action,” Pharmacological Research, vol. 63, no. 2, pp. 102–107, 2011.
- X.-C. Dou, X.-P. Zhu, J. Zhou, H.-Q. Cai, J. Tang, and Q.-L. Li, “Minocycline-released hydroxyapatite–gelatin nanocomposite and its cytocompatibility in vitro,” Biomedical Materials, vol. 6, no. 2, Article ID 025002, 2011.
- X. Song, F. Ling, L. Ma, C. Yang, and X. Chen, “Electrospun hydroxyapatite grafted poly(l-lactide)/poly(lactic-co-glycolic acid) nanofibers for guided bone regeneration membrane,” Composites Science and Technology, vol. 79, pp. 8–14, 2013.
- M. Kikuchi, Y. Koyama, T. Yamada et al., “Development of guided bone regeneration membrane composed of β-tricalcium phosphate and poly (L-lactide-co-glycolide-co-ε-caprolactone) composites,” Biomaterials, vol. 25, no. 28, pp. 5979–5986, 2004.
- P. Karuppuswamy, J. R. Venugopal, B. Navaneethan, A. L. Laiva, and S. Ramakrishna, “Polycaprolactone nanofibers for the controlled release of tetracycline hydrochloride,” Materials Letters, vol. 141, pp. 180–186, 2015.
- H. Maeda and T. Kasuga, “Control of silicon species released from poly(lactic acid)-polysiloxane hybrid membranes,” Journal of Biomedical Materials Research Part A, vol. 85, no. 3, pp. 742–746, 2008.
- E.-J. Lee, D.-S. Shin, H.-E. Kim, H.-W. Kim, Y.-H. Koh, and J.-H. Jang, “Membrane of hybrid chitosan-silica xerogel for guided bone regeneration,” Biomaterials, vol. 30, no. 5, pp. 743–750, 2009.
- L. J. Xu, L. Y. Jiang, C. D. Xiong, L. X. Jiang, and Y. Li, “Study on a novel double-layered composite membrane of Mg-substituted nano-hydroxyapatite/ poly(L-lactide-co-ε-caprolactone): effect of different L-l act ide/ε- caprolactone ratios,” Materials science and Engineering A: Structural Materials: Properties, Microstructure and Processing, vol. 615, pp. 361–366, 2014.
- C.-H. Lai, L. Zhou, Z.-L. Wang, H.-B. Lu, and Y. Gao, “Use of a collagen membrane loaded with recombinant human bone morphogenetic protein-2 with collagen-binding domain for vertical guided bone regeneration,” Journal of Periodontology, vol. 84, no. 7, pp. 950–957, 2013.
- B. A. Al-Hazmi, K. S. Al-Hamdan, A. Al-Rasheed, N. Babay, H.-L. Wang, and K. Al-Hezaimi, “Efficacy of using PDGF and xenograft with or without collagen membrane for bone regeneration around immediate implants with induced dehiscence-type defects: a microcomputed tomographic study in dogs,” Journal of Periodontology, vol. 84, no. 3, pp. 371–378, 2013.
Copyright © 2015 YuYuan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.